Profound Medical (PROF) Cash from Financing Activities (2024 - 2025)
Profound Medical's (PROF) quarterly Cash from Financing Activities came in at $41.4 million in Q4 2025, up 16.91% year-on-year from $35.4 million in Q4 2024, and up 14385.52% quarter-over-quarter from -$290000.0 in Q1 2025.
Profound Medical (PROF) Cash from Financing Activities (2024 - 2025) Analysis & Trends
Profound Medical's Cash from Financing Activities history runs 2 years deep, the most recent figure standing at $41.4 million for Q4 2025.
- On a quarterly basis, Cash from Financing Activities rose 16.91% year-over-year to $41.4 million in Q4 2025; TTM through Dec 2025 was $41.1 million, a 24.79% decrease from a year earlier, with the FY2025 full-year figure at $41.1 million, down 24.79% from the prior year.
- Cash from Financing Activities improved to $41.4 million in Q4 2025 per PROF's latest filing, from -$290000.0 in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $41.4 million in Q4 2025 and bottomed at -$603000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -25.00 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -26.93 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Profound Medical | 248.64 Mn | 198.34 Mn | 3.83 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 41.43 Mn |
| Dec 31, 2025 | 41.43 Mn |
| Mar 31, 2025 | -290,000.00 |
| Mar 31, 2025 | -290,000.00 |
| Dec 31, 2024 | 35.44 Mn |
| Dec 31, 2024 | 35.44 Mn |
| Sep 30, 2024 | -592,000.00 |
| Sep 30, 2024 | -592,000.00 |
| Jun 30, 2024 | -603,000.00 |
| Jun 30, 2024 | -603,000.00 |
| Mar 31, 2024 | 20.46 Mn |
| Mar 31, 2024 | 20.46 Mn |